Has the Landscape of Immunotherapy for Prostate Cancer Changed? A Systematic Review and Post Hoc Analysis

Prostate cancer (PCa) is the second leading cause of cancer-causing death in the United States. As the most common malignancy in men, it is pertinent to explore whether novel immunotherapies may improve the quality of life and overall survival (OS) of patient populations. This systematic review and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashraf, Muhammad Usman, Farwa, Ume, Siddiqa, Maryam, Sarfraz, Azza, Azeem, Nishwa, Sarfraz, Zouina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Prostatic Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069001/
https://www.ncbi.nlm.nih.gov/pubmed/37002863
http://dx.doi.org/10.1177/15579883231165140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069001/
https://www.ncbi.nlm.nih.gov/pubmed/37002863
http://dx.doi.org/10.1177/15579883231165140

Ejemplares similares